So, lets take your more conservative approach of $12.91 and assume the GM maintains at 59%. This will deliver a gross margin of $7.6M, which is higher than last years expenses (taking out non cash items, such as depreciation). I would expect operational cashflow to be positive, depending on how much stock/inventory is accumulated going into FY25. But a significant milestone appears to be on the horizon.
So, lets take your more conservative approach of $12.91 and...
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.050(17.9%) |
Mkt cap ! $70.23M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 33.0¢ | 29.0¢ | $18.53K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 2564 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
31.0¢ |
Change
0.050 ( 9.46 %) |
||||
| Open | High | Low | Volume | ||
| 29.5¢ | 32.0¢ | 29.5¢ | 102197 | ||
| Last updated 15.58pm 07/05/2024 ? | |||||
| BIO (ASX) Chart |